Population-Based vs Health System and Insurer Records: Significant Underdiagnosis of PCOS - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Comparing Population Data with Health System and Insurance Records: Notable Underdiagnosis of PCOS

  • By

  • Sana Hatoum

  • Mina Amiri

  • Dawnkimberly Hopkins

  • Richard P Buyalos

  • Fernando Bril

  • Ricardo Azziz

  • January 21, 2025

Share

Clinical Scorecard: Comparing Population Data with Health System and Insurance Records: Notable Underdiagnosis of PCOS

At a Glance

CategoryDetail
ConditionPolycystic ovary syndrome (PCOS)
Key MechanismsComplex genetic trait causing cardiometabolic and reproductive morbidity, including hypertension, metabolic syndrome, cardiovascular events, and mental health disorders
Target PopulationWomen, especially during reproductive years
Care SettingPopulation-based studies and Health System or Insurer Records (HSIR) settings

Key Highlights

  • PCOS prevalence is substantially underreported in Health System and Insurer Records compared to population-based studies across the US, UK, and South Korea.
  • Underdiagnosis or underreporting of PCOS may delay timely intervention, increasing risks of physical and mental health complications.
  • Improved awareness among healthcare practitioners, payers, and the public is critical to address the underdiagnosis of PCOS.

Guideline-Based Recommendations

Diagnosis

  • Use established diagnostic criteria such as 1990 NIH, 2003 Rotterdam, or 2006 AE-PCOS criteria for PCOS diagnosis.
  • Consider population-based screening approaches to identify undiagnosed PCOS cases.

Management

  • Timely diagnosis and intervention are essential to manage metabolic status and comorbidities associated with PCOS.
  • Provide counseling addressing both physical and mental health aspects of PCOS.

Monitoring & Follow-up

  • Regular assessment for hypertension, metabolic syndrome, cardiovascular risks, and mental health disorders in diagnosed PCOS patients.

Risks

  • Delayed or missed diagnosis can lead to increased cardiometabolic complications and mental health disorders.
  • Underreporting in health records may hinder appropriate healthcare resource allocation.

Patient & Prescribing Data

Women with PCOS identified in population-based and health system datasets

Data indicate a gap in diagnosis that may affect timely treatment initiation and management of associated comorbidities.

Clinical Best Practices

  • Increase clinician and payer awareness of PCOS prevalence and diagnostic criteria to reduce underdiagnosis.
  • Incorporate systematic screening and accurate coding in electronic health records to improve detection rates.
  • Address both physical and mental health impacts of PCOS in patient management plans.

References

Original Source(s)

Related Content